A novel fibroblast growth factor 1 variant reverses nonalcoholic fatty liver disease in type 2 diabetes.Qian LinUnknownJanuary 1, 201810.18297/etd/3016Cited by 1SaveCiteExport RISWatch citationsRelated PapersPhysicochemical and In Vitro Evaluation of Drug Delivery of an Antibacterial Synthetic Benzophenone in Biodegradable PLGA Nanoparticles|AAPS PharmSciTech|2018|7